Theolytics (private company)
See something wrong or missing? Let us know
Offices:Oxford
Industry:BiotechHealth servicesPharma
Business model:B2B
Theolytics is focused on creating a step-change in the oncolytic viral therapy field, by using its phenotypic screening platform to discover and develop highly efficacious, targeted candidates, suitable for intravenous delivery and optimised for a chosen cancer patient population.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 59M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Theolytics
Name | Criteria | |
---|---|---|
![]() |
AbolerIS Pharma
70%
|
|
![]() |
Acesion Pharma
70%
|
|
![]() |
NMD Pharma
70%
|
|
![]() |
Sanifit Therapeutics
70%
|
|
![]() |
Synklino
70%
|
|
![]() |
Cytoki Pharma
70%
|
|
![]() |
Causaly
70%
|
|
![]() |
Cardior Pharmaceuticals
70%
|
|
![]() |
PetMedix
70%
|
|
![]() |
Asgard Therapeutics
70%
|
|